Epidemiology of Angioid Streaks and Pseudoxanthoma Elasticum (2011-2020): A Nationwide Population-based Cohort Study

Saori Wada; Masahiro Miyake; Ai Kido; Takuro Kamei; Shusuke Hiragi; Hanako Ohashi Ikeda; Masayuki Hata; Hiroaki Ueshima; Akitaka Tsujikawa; Hiroshi Tamura

doi:10.1016/j.xops.2023.100370

Epidemiology of Angioid Streaks and Pseudoxanthoma Elasticum (2011-2020): A Nationwide Population-based Cohort Study

Ophthalmol Sci. 2023 Jul 20;4(2):100370. doi: 10.1016/j.xops.2023.100370. eCollection 2024 Mar-Apr.

Authors

Saori Wada¹, Masahiro Miyake¹, Ai Kido^{1

2}, Takuro Kamei¹, Shusuke Hiragi³, Hanako Ohashi Ikeda¹, Masayuki Hata¹, Hiroaki Ueshima⁴, Akitaka Tsujikawa¹, Hiroshi Tamura^{1

4}

Affiliations

¹ Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.
² Kyoto Okamoto Memorial Hospital, Kyoto, Japan.
³ Medical Research Institute KITANO HOSPITAL, PIIF Tazuke-kofukai, Osaka, Japan.
⁴ Center for Innovative Research and Education in Data Science, Institute for Liberal Arts and Sciences, Kyoto University, Kyoto, Japan.

Abstract

Purpose: We aimed to describe the epidemiology of angioid streaks (AS) and pseudoxanthoma elasticum (PXE), which are rare diseases, using a national claims database.

Design: This was a population-based longitudinal cohort study.

Participants: A total of 126 million individuals were covered by the universal health coverage system in Japan.

Methods: With permission from the Ministry of Health, Labor and Welfare, we accessed all data from the National Database of Health Insurance Claims and Specific Health Checkups of Japan, which contains the nationwide health insurance claims data for 126 million Japanese. We identified individuals with AS and PXE between January 2011 and December 2020. The incidence rates, prevalence, overlap of AS and PXE, and mean age at death were calculated.

Main outcome measures: The incidence rates and prevalence of AS and PXE.

Results: A total of 6598 cases of AS and 1020 cases of PXE were identified during the 10-year study period. The incidence rates of AS and PXE were 0.52 (95% confidence interval, 0.48-0.56) and 0.08 (95% confidence interval, 0.07-0.10) per 100 000 person-years, respectively. On October 1, 2020, the prevalence of AS and PXE was 6.5 (95% confidence interval, 6.38-6.66) and 0.83 (95% confidence interval, 0.78-0.89) per 100 000 persons, respectively. The overlap of AS and PXE was 363 patients. The mean age at death of individuals with AS and PXE was 79.3 ± 0.51 and 77.1 ± 2.68 years, respectively.

Conclusion: This is the first population-based study to elucidate the epidemiology of AS and PXE. The mean age of death of both AS and PXE patients was younger than the mean life expectancy of the general Japanese population, thus, appropriate diagnosis and management are important to avoid preventable death.

Financial disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

Keywords: Angioid streaks; Epidemiology; Incidence; Prevalence; Pseudoxanthoma elasticum.